# Anti-Cytokine Therapy for Vasculitis

> **NCT00753103** · PHASE2 · COMPLETED · sponsor: **University Hospital Birmingham NHS Foundation Trust** · enrollment: 37 (actual)

## Conditions studied

- Wegener's Granulomatosis
- Renal Limited Vasculitis
- Microscopic Polyangiitis

## Interventions

- **BIOLOGICAL:** Infliximab
- **DRUG:** Cyclophosphamide
- **DRUG:** Prednisolone
- **DRUG:** Azathioprine
- **PROCEDURE:** Plasma exchange
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT00753103
- **Lead sponsor:** University Hospital Birmingham NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2008-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00753103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00753103, "Anti-Cytokine Therapy for Vasculitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00753103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*